FDA is removing barriers to real-world evidence in device applications, allowing the use of de-identified patient data from ...
The FDA’s oversight of medical device recalls continues to be plagued by staffing challenges—forcing some activities to be ...
Neuralink, Elon Musk’s frothy brain-computer interface company, poached David McMullen, director of FDA’s office of ...
The FDA recently had a meeting to explore regulatory aspects of AI-enabled mental health medical devices. I explore a useful ...
This week in Pedersen's POV, our senior editor finds humor in the European Commmission's plan to simplify the EU Medical ...
The FDA's scrutiny of WHOOP highlights increasing challenges for niche wearable device makers as they navigate regulatory ...
FDA's challenges — such as insufficient staffing — can create inefficiencies in the process and potentially put lives at risk ...
Medical Device Network on MSN
What 2025 reveals about medtech’s next leap in 2026
No one can predict what the medical device industry will look like in 2026. Still, the events of 2025 provide meaningful ...
Navigating the SaMD regulatory pathways is one of the most complex yet important aspects of product development for medical technology startups. Startups in this field are required to meet local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results